The modern management of Parkinson's disease.
- 1 February 1990
- journal article
- review article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 53 (2) , 93-95
- https://doi.org/10.1136/jnnp.53.2.93
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Effect of Deprenyl on the Progression of Disability in Early Parkinson's DiseaseNew England Journal of Medicine, 1989
- Subcutaneous apomorphine in Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1989
- SIDE-EFFECTS OF SUBCUTANEOUS APOMORPHINE IN PARKINSON'S DISEASEThe Lancet, 1989
- Multicenter Study of Autologous Adrenal Medullary Transplantation to the Corpus Striatum in Patients with Advanced Parkinson's DiseaseNew England Journal of Medicine, 1989
- SUBCUTANEOUS APOMORPHINE FOR ON-OFF OSCILLATIONS IN PARKINSON'S DISEASEThe Lancet, 1988
- SUBCUTANEOUS APOMORPHINE IN PARKINSON'S DISEASEThe Lancet, 1988
- Increased life expectancy resulting from addition of l-deprenyl to Madopar® treatment in Parkinson's disease: A longterm studyJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1985
- Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitorsNature, 1984
- L-Dopa Methyl Ester—A Candidate for Chronic Systemic Delivery of L-Dopa in Parkinsonʼs DiseaseClinical Neuropharmacology, 1984
- The potentiation of the anti akinetic effect after L-Dopa treatment by an inhibitor of Mao-B, deprenilJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1975